The genetic heterogeneity of mendelian susceptibility to mycobacterial diseases

Saleh Al-Muhsen1, Jean-Laurent Casanova

  • 1Department of Pediatrics, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia. smohsen@kfshrc.edu.sa

Insights

Primary immunodeficiencies (PIDs) are increasingly recognized beyond recessive traits, with Mendelian susceptibility to mycobacterial diseases (MSMD) showing significant genetic heterogeneity. Further research is expected to uncover new genetic causes for MSMD across various inheritance patterns.

Area of Science:

  • Immunology
  • Genetics
  • Infectious Diseases

Background:

  • Primary immunodeficiencies (PIDs) were historically considered exclusively recessive (autosomal recessive [AR] or X-linked recessive [XR]).
  • Recent discoveries include autosomal dominant (AD), mitochondrial, polygenic, and somatic PIDs, though AR remains prevalent.
  • Mendelian susceptibility to mycobacterial diseases (MSMD) exemplifies PID genetic heterogeneity.

Purpose of the Study:

  • To review the genetic basis and inheritance patterns of Primary Immunodeficiencies (PIDs).
  • To highlight the genetic heterogeneity of Mendelian susceptibility to mycobacterial diseases (MSMD).
  • To discuss the known and potential future genetic etiologies of MSMD.

Main Methods:

  • Literature review of genetic studies on Primary Immunodeficiencies (PIDs).
  • Analysis of known genetic causes and inheritance patterns for Mendelian susceptibility to mycobacterial diseases (MSMD).
  • Categorization of MSMD genetic disorders by inheritance (AR, AD, XR) and affected genes.

Main Results:

  • MSMD involves 6 genes: NEMO (XR), IFNGR1 (AD/AR), IFNGR2 (AR), STAT1 (AD), IL12P40 (AR), and IL12RB1 (AR).
  • Thirteen genetic disorders cause MSMD: 1 XR, 3 AD (2 genes), and 9 AR (4 genes).
  • Genetic etiology remains unidentified in approximately half of MSMD patients.

Conclusions:

  • MSMD exhibits significant genetic heterogeneity with diverse inheritance patterns.
  • New X-linked recessive (XR) and autosomal dominant (AD) causes of MSMD are anticipated.
  • Further discovery of autosomal recessive (AR) MSMD etiologies is likely, particularly in populations with consanguinity.

Related Concept Videos

Mismatch Repair01:36

Mismatch Repair

Overview
38.1K
Incomplete Dominance01:43

Incomplete Dominance

Gregor Mendel's work (1822 - 1884) was primarily focused on pea plants. Through his initial experiments, he determined that every gene in a diploid cell has two variants called alleles inherited from each parent. He suggested that amongst these two alleles, one allele is dominant in character and the other recessive. The combination of alleles determines the phenotype of a gene in an organism.
18.9K
Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
5.4K
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
137
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
157
Genetic Variation01:25

Genetic Variation

Genetic variation is the diversity in DNA sequences found among individuals of the same species. This diversity is crucial for a species' survival because it helps organisms adapt to environmental changes. Genetic variation begins with fertilization, where an egg and sperm cell merge. Each of these cells carries 23 chromosomes, up to 46 in the fertilized egg. Chromosomes are long DNA strands that contain genes, the basic units of heredity.
Genes exist in different versions called alleles,...
1.6K